INS and type 2 diabetes mellitus: Whilst cohort studies relating whey and casein per se to CV and T2D outcomes are lacking, RCTs have identified beneficial moderate-term effects of whey protein on intermediary risk factors including lipids and lipoproteins, blood pressure, and glucose-related parameters including insulin secretion.